Home » Topics » Regulatory » Patents

Patents
RSS

EPC-K claimed for ophthalmic use

May 3, 1996

Hybridon reports oligonucleotide MDR inhibitors

May 3, 1996

Sankyo macrophage activators claimed as immunostimulants, antineoplastics

May 3, 1996

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

Fujisawa reports collagenase inhibitors

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Malaria vaccine lead reported by Johns Hopkins

May 3, 1996

Sankyo reveals HIV protease inhibitors

May 3, 1996

Gen-Probe's oligonucleotides inhibit HIV proliferation

May 3, 1996

Roche claims stable ganciclovir prodrugs

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 12, 2025.
Could restricting diversity efforts stall women’s health research?
BioWorld
Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash against diversity, equity and...
Alkermes’ alixorexton hits endpoints in narcolepsy phase II
BioWorld
Alkermes plc’s placebo-controlled phase II study of alixorexton in treating narcolepsy type 2 (NT2) hit its dual primary endpoints, producing statistically...
Pazdur ‘optimal fit’ to lead FDA’s CDER
BioWorld
In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to...